Evgen Pharma plc
Company Profile
Company website
Sector
Health Care Equipment and Services (Medical Equipment)
Description
A clinical stage drug development company focused on cancer and neurological disease. The Company's core technology is Sulforadex®, a means of synthesising and concurrently stabilising the naturally occurring compound sulforaphane which has anti-cancer and neuroprotective characteristics.
Not all Walbrook clients have a handy 2 page summary available. Click on "Register your interest" and we'll let the Company know that you think this would be useful
Investment

Investment
Summary
Investor Access Events
14
Jan
Event information
Investor presentation
Venue
Copper bar, Balls Brothers, 6 Adams Court, Old Broad St, London EC2N 1DX
Time
4.30pm for a 4.45pm start